z-logo
open-access-imgOpen Access
Efficacy and safety of intravenous paricalcitol treatment in Chinese hemodialysis patients: a real-world database analysis
Author(s) -
Niansong Wang,
Yuting Xie,
Gengru Jiang
Publication year - 2022
Publication title -
annals of palliative medicine
Language(s) - English
Resource type - Journals
eISSN - 2224-5839
pISSN - 2224-5820
DOI - 10.21037/apm-21-3966
Subject(s) - paricalcitol , medicine , secondary hyperparathyroidism , hemodialysis , parathyroid hormone , retrospective cohort study , urology , dialysis , calcium
The aim of this retrospective observational study based on real-world data was to evaluate the efficacy and safety profile of paricalcitol in Chinese hemodialysis (HD) patients with secondary hyperparathyroidism (SHPT) in routine clinical practice.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom